Neogenomics (NEO) Asset Writedowns and Impairment (2010 - 2025)
Neogenomics' (NEO) quarterly Asset Writedowns and Impairment came in at $673000.0 in Q4 2025, up 302.99% YoY from $167000.0 in Q4 2024, and down 90.5% on a QoQ basis from $7.1 million in Q3 2025.
Neogenomics (NEO) Asset Writedowns and Impairment (2010 - 2025) Analysis & Trends
Neogenomics (NEO) has 12 years of Asset Writedowns and Impairment data on file, last reported at $673000.0 in Q4 2025.
- Quarterly Asset Writedowns and Impairment rose 302.99% year-over-year to $673000.0 in Q4 2025, while the trailing twelve-month figure through Jun 2026 was $27.8 million (up 37.57% YoY) and the FY2025 annual result came in at $27.8 million, up 5460.0% from the prior year.
- Asset Writedowns and Impairment slipped to $673000.0 in Q4 2025, from $7.1 million in the prior quarter.
- In the past five years, Asset Writedowns and Impairment ranged from a high of $20.0 million in Q2 2025 to a low of $43000.0 in Q3 2023.
- A 4-year average of $3.4 million and a median of $718000.0 in 2022 frame the typical range for Asset Writedowns and Impairment.
- Annual changes were most pronounced in 2024 — Asset Writedowns and Impairment plunged 84.29% — and 2025, when it jumped 302.99%.
- Tracing NEO's Asset Writedowns and Impairment over 4 years: stood at $718000.0 in 2022, then plunged by 94.01% to $43000.0 in 2023, then soared by 288.37% to $167000.0 in 2024, then jumped by 302.99% to $673000.0 in 2025.
- The last three Asset Writedowns and Impairment figures came in at $673000.0 (Q4 2025), $7.1 million (Q3 2025), and $20.0 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn |
| 10 | Neogenomics | 2.42 Bn | 2.28 Bn | 91.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 673,000.00 |
| Dec 31, 2025 | 673,000.00 |
| Sep 30, 2025 | 7.09 Mn |
| Sep 30, 2025 | 7.09 Mn |
| Jun 30, 2025 | 20.04 Mn |
| Jun 30, 2025 | 20.04 Mn |
| Dec 31, 2024 | 167,000.00 |
| Dec 31, 2024 | 167,000.00 |
| Mar 31, 2024 | 145,000.00 |
| Mar 31, 2024 | 145,000.00 |
| Sep 30, 2023 | 43,000.00 |
| Sep 30, 2023 | 43,000.00 |
| Jun 30, 2023 | 737,000.00 |
| Jun 30, 2023 | 737,000.00 |
| Mar 31, 2023 | 923,000.00 |
| Mar 31, 2023 | 923,000.00 |
| Dec 31, 2022 | 718,000.00 |
| Dec 31, 2022 | 718,000.00 |
| Dec 31, 2017 | 5.62 Mn |
| Dec 31, 2017 | 5.62 Mn |